Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Prostate Carcinoma”

539 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 539 results

Testing effectiveness (Phase 2)Ended earlyNCT00670046
What this trial is testing

Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Large-scale testing (Phase 3)Study completedNCT00030654
What this trial is testing

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 21
Testing effectiveness (Phase 2)Study completedNCT00964002
What this trial is testing

Efavirenz in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Institut Bergonié 61
Testing effectiveness (Phase 2)Study completedNCT00085228
What this trial is testing

Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 116
Early research (Phase 1)Study completedNCT03076203
What this trial is testing

Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad)

Who this might be right for
Prostate Carcinoma Metastatic to the BoneStage IV Prostate AdenocarcinomaHormone-refractory Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Testing effectiveness (Phase 2)WithdrawnNCT05034562
What this trial is testing

Gallium-68 PSMA-11 PET in Participants With Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer AJCC v8+2 more
M.D. Anderson Cancer Center
Not applicableUnknownNCT01562223
What this trial is testing

Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate Cancer

Who this might be right for
Prostate Cancer
American College of Radiology Imaging Network 30
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT00003614
What this trial is testing

Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT02280317
What this trial is testing

Dose Finding Safety Study of VAL201 in Cancer Patients

Who this might be right for
Stage III Prostate CarcinomaStage IV Prostate Carcinoma
ValiRx Plc 12
Post-approval studies (Phase 4)Study completedNCT01649635
What this trial is testing

Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sanofi 45
Not applicableStudy completedNCT03112668
What this trial is testing

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

Who this might be right for
Malignant Female Reproductive System NeoplasmMalignant Hepatobiliary NeoplasmPartner+36 more
Rutgers, The State University of New Jersey 14
Testing effectiveness (Phase 2)Study completedNCT00020891
What this trial is testing

CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who Are Undergoing Radiation Therapy

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT03707184
What this trial is testing

Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone

Who this might be right for
Metastatic Prostate CarcinomaProstate Carcinoma Metastatic in the BoneStage IV Prostate Cancer
University of Utah 17
Large-scale testing (Phase 3)WithdrawnNCT00041171
What this trial is testing

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Adult Solid TumorBreast CancerHead and Neck Cancer+3 more
Alliance for Clinical Trials in Oncology
Not applicableStudy completedNCT00544336
What this trial is testing

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+3 more
Vanderbilt-Ingram Cancer Center 366
Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Large-scale testing (Phase 3)Study completedNCT00329797
What this trial is testing

Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy

Who this might be right for
OsteoporosisProstate Cancer
Radiation Therapy Oncology Group 109
Testing effectiveness (Phase 2)Ended earlyNCT04754425
What this trial is testing

Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaCastration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted AgentsMetastatic Malignant Neoplasm in the Bone+5 more
M.D. Anderson Cancer Center 11
Not applicableStudy completedNCT01812668
What this trial is testing

Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
Barbara Ann Karmanos Cancer Institute 20
Load More Results